---
title: "Endothelial PGE2 drives macrophage M1 polarization and pyroptosis via EP4/TREM1 in glucocorticoid-"
id: "frontiers-in-immunology-11-endothelial-pge2-initiates-macrophage-m1-polarization-and-pyroptosis-via-ep4"
canonical_url: "https://medichelpline.com/clinical-feed/frontiers-in-immunology-11-endothelial-pge2-initiates-macrophage-m1-polarization-and-pyroptosis-via-ep4"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "Frontiers in Immunology"
source_url: "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1962346"
published_at: "2026-11-16T00:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Endothelial PGE2 drives macrophage M1 polarization and pyroptosis via EP4/TREM1 in glucocorticoid-
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/frontiers-in-immunology-11-endothelial-pge2-initiates-macrophage-m1-polarization-and-pyroptosis-via-ep4
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** Frontiers in Immunology
- **Source URL:** [Original Journal Publication](https://www.frontiersin.org/articles/10.3389/fimmu.2026.1962346)
- **Published At:** 2026-11-16T00:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- The article title states that endothelial-derived **PGE2** initiates macrophage **M1** polarization and **pyroptosis** through the **EP4/TREM1** signaling axis in the setting of **glucocorticoid-induced osteonecrosis of the femoral head**. - Authors reported a mechanistic linkage between endothelial signaling and innate immune activation (macrophage phenotype shift to M1) in this disease context. - The title indicates involvement of the prostaglandin receptor **EP4** and the triggering receptor expressed on myeloid cells **TREM1** as mediators of this process. - The study team observed macrophage death by inflammasome-associated cell death (pyroptosis) downstream of the EP4/TREM1 pathway, according to the title. - The source article text available to this rewrite did not report experimental design details, sample sizes, quantitative results, or statistical endpoints. - Specific methods (animal models, cell types studied, dosing regimens, time points, or molecular assays) were not provided in the available source content and therefore are not stated here. - The title implies potential therapeutic targets—endothelial **PGE2**, **EP4**, and **TREM1**—but the source did not document interventional or translational data supporting clinical efficacy or safety. - Limitations and unanswered questions include whether systemic or local PGE2 drives the effect, how glucocorticoids alter endothelial PGE2 production, and whether blocking EP4 or TREM1 prevents bone necrosis; the article text accessible did not answer these points. - The study’s full experimental results and contextual data were not available in the provided source excerpt; readers should consult the full Frontiers in Immunology article for raw data and methods.
## Clinical Analysis & Structured Key Points
Frontiers | Endothelial PGE2 initiates macrophage M1 polarization and pyroptosis via EP4/TREM1 axis in glucocorticoid-induced osteonecrosis of the femoral head ORIGINAL RESEARCH article Front. Immunol. , 16 November 2026 Sec. Inflammation Volume 17 - 2026 | https://doi.org/10.3389/fimmu.2026.1962346 Published in Frontiers in Immunology Inflammation 7 impact factor 11.3 citescore Part of a Research Topic Revisiting endothelial biology: Immune sentinels of the vasculature in inflammation and disease Submission open 3767 views 3 articles Editor & Reviewers Edited by B H Baharak Hosseinkhani Reviewed by W Q Wentao Qin S D Shengnan Du Outline Figures and Tables Figure 1 View in article Figure 2 View in article Figure 3 View in article Figure 4 View in article Figure 5 View in article Figure 6 View in article Figure 7 View in article ORIGINAL RESEARCH article Front. Immunol. , 16 November 2026 Sec. Inflammation Volume 17 - 2026 | https://doi.org/10.3389/fimmu.2026.1962346 Endothelial PGE2 initiates macrophage M1 polarization and pyroptosis via EP4/TREM1 axis in glucocorticoid-induced osteonecrosis of the femoral head W S Wenkai Shao 1,2 † P W Ping Wang 1 † S G Song Gong 3 Y W Yuxi Wang 1 X L Xiao Lv 1 Y T Yihao Tao 1 X S Xianzhe Si 4 B W Bo Wang 5 * Y F Yong Feng 1 * 1. Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China 2. Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, China 3. Department of Orthopaedics, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China 4. Department of Gastrointestinal, Hernia and Abdominal Wall Surgery, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China 5. Department of Rehabilitation, Wuhan No. 1 Hospital, Wuhan, China See more Article metrics View details Abstract Background: Endothelial cells interact with macrophages, influencing their function and playing pivotal roles in various bone-related pathologies. Osteonecrosis of the femoral head (ONFH) is a debilitating bone disorder strongly linked to inflammation. Glucocorticoid (GC)-induced ONFH is associated with a higher degree of macrophage infiltration and more pronounced local inflammation compared to alcohol-induced or trauma-related osteonecrosis. However, the complex relationship between endothelial cells and macrophages under GC stimulation, as well as the mechanisms underlying osteonecrosis, remains poorly understood. Methods: Bioinformatics approaches were utilized to identify key molecules and pathways involved in pyroptosis during ONFH. TREM1 and PTGS2 (COX2) were identified as critical mediators of pyroptosis in chronic inflammatory processes. Endothelial COX2-specific knockout mice were generated to examine the role of PGE2 in GC-induced ONFH. Micro-CT, immunofluorescence (IF), hematoxylin and eosin (H&E) staining, quantitative reverse transcription PCR (qRT-PCR), western blotting, and flow cytometry were utilized to examine alternations in cellular and tissue components. Results: GC treatment was found to upregulate endothelial PTGS2, leading to increased secretion of prostaglandin E2 (PGE2). Elevated PGE2 levels increased TREM1 expression through the P38-MAPK pathway, mediated by the macrophage EP4 receptor. This activation initiated a positive feedback loop, promoting the polarization of pro-inflammatory M1-like macrophages and triggering pyroptosis. Conclusion: The findings provide fresh perspectives on the mechanisms of early inflammation in GC-induced ONFH, highlighting the role of endothelial-macrophage crosstalk. TREM1 and PTGS2 were identified as crucial mediators of pyroptosis, contributing to chronic inflammation and the progression of osteonecrosis. 1 Introduction Non-traumatic osteonecrosis of the femoral head is a common bone disease that seriously affects the quality of life due to its rapid progression and high disability rate ( 1 ). In the United States, the annual incidence of NONFH ranges from 10,000 to 20,000 new cases, with a steadily increasing trend that imposes substantial economic burdens on healthcare systems worldwide ( 2 ). Among all subtypes, glucocorticoid (GC)-induced ONFH is the most common, predominantly affecting individuals of young and middle age. The early inflammatory response aims to eliminate detrimental stimuli and facilitate repair; however, chronic inflammation persists due to necrosis of marrow and bone cells, along with aberrant activation of immune cells, obstructing local repair and ultimately resulting in femoral head collapse. Management of GC-ONFH depends largely on disease stage. Early-stage disease may be treated conservatively or with core decompression, with or without bone grafting or cell-based therapies, whereas total hip arthroplasty is generally reserved for advanced disease. Pharmacological treatments such as bisphosphonates have also been explored, but their efficacy in preventing femoral head collapse remains uncertain ( 3 ). Pyroptosis is a gasdermin-mediated form of inflammatory cell death characterized by plasma membrane pore formation, cell swelling, membrane rupture, and release of proinflammatory factors ( 4 ). Pyroptosis has been implicated in various bone diseases, including osteoporosis, osteoarthritis, osteomyelitis, and osteonecrosis ( 5 , 6 ). Recently, macrophage pyroptosis has emerged as a key focus in light of inflammation-related diseases ( 7 ). Macrophages exhibit environment-specific phenotypes, with proinflammatory M1-like macrophages promoting osteoclast-mediated bone resorption, while anti-inflammatory M2-like macrophages support osteogenesis and mineralization ( 8 ). M1-like macrophage polarization and pyroptosis are closely related. The activation of M1-like macrophages enhances the release of proinflammatory factors, thereby exacerbating cellular inflammatory damage. Macrophage pyroptosis further causes the release of many proinflammatory factors, delaying wound healing and tissue repair ( 9 ). Animal models have confirmed that early elimination of M1-like macrophages significantly delays the course of the GC-induced ONFH ( 10 ). Our research, along with others, demonstrates that blood vessels are crucial for protecting the femoral head, and endothelial damage can promote M1-like macrophage polarization and aberrant immune system activation via paracrine mechanisms ( 11 , 12 ). However, the interaction between endothelial cells and macrophages in the development of chronic inflammation in osteonecrosis remains enigmatic. Elucidating endothelial–macrophage crosstalk may reveal early therapeutic targets linking vascular injury to inflammatory activation and provide a rationale for delaying disease progression before femoral head collapse. Triggering receptor expressed on myeloid cells 1 (TREM1), a transmembrane receptor of the immunoglobulin-like family, is identified as an enhancer of inflammation in innate immunity ( 13 ). This receptor is inducible in immune cells, including macrophages, and facilitates the secretion of inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), which are critical for the onset and amplification of inflammation ( 14 ). TREM1 has been recognized for its role in promoting the M1-like macrophage polarization and exacerbating alveolar bone loss in the context of periodontitis ( 15 ). The function of TREM1 in macrophage polarization and pyroptosis, along with its putative mechanism in GC-induced ONFH, remains to be elucidated. In this study, we aim to explore the mechanism of chronic inflammation in CG-induced ONFH. Utilizing bioinformatics technology, we identified TREM1 and PTGS2 as key molecules that mediate pyroptosis in the continuous progression of inflammation during osteonecrosis. TREM1 and prostaglandin-endoperoxide synthase 2 (PTGS2), also known as cyclooxygenase-2 (COX-2), were highly expressed in M1-like macrophages and endothelial cells, respectively. Further in vivo and in vitro experiments confirmed that GC promotes the secretion of prostaglandin E2 (PGE2) by upregulating endothelial PTGS2. Excessive PGE2 levels promote the TREM1 upregulation through the p38 mitogen-activated protein kinase (MAPK) signaling, mediated by prostaglandin E2 receptor subtype 4 (EP4) in macrophages. TREM1 activation triggers a positive feedback loop that further activates the p38 MAPK pathway in macrophages, leading to M1-like macrophage polarization and pyroptosis. We offered a novel perspective on the process of early inflammation in GC-induced ONFH through the lens of endothelial-macrophage interaction. 2 Materials and methods 2.1 Screening of differentially expressed genes The microarray data of the GSE123568 dataset were obtained from the Gene Expression Omnibus (GEO) database (GPL15207 platform, Affymetrix human gene expression array). GSE123568 includes 30 peripheral serum samples from Steroid-associated ONFH patients and 10 from normal controls, with a total of 40 samples. The NetworkAnalyst ( https://www.networkanalyst.ca/ ) online tool was used to compare the expression values of SONFH patient samples with those of normal control samples in order to investigate the differentially expressed genes (DEGs). The study’s cutoff parameters for finding DEGs were a logarithmic fold difference value larger than 1.0 and an adjusted P value less than 0.01. 2.2 Identification of differentially expressed genes Candidate pyroptosis-associated genes were retrieved from the GeneCards database ( https://www.genecards.org/ , accessed May 1, 2023) using the keyword “pyroptosis”. GeneCards was used as a broad candidate-discovery resource rather than a strictly curated database of experimentally validated pyroptosis regulators. Subsequently, differentially expressed genes (DEGs) identified from GSE123568 were intersected with the GeneCards-derived candidate genes using the online platform HiPlot ( https://hiplot.com.cn/ ), and the overlapping genes were visualized using a Venn diagram. These overlapping genes were defined as candidate pyroptosis-associated DEGs and subjected to subsequent bioinformatics analyses. To further characterize the biological evidence supporting these candidates, the 41 overlapping genes were additionally assessed using selected curated reference gene sets, including Reactome Pyroptosis (R-HSA-5620971) and Gene Ontology (GO:0070269 and GO:0141201), together with published experimental literature. This supplementary assessment was conducted to clarify the sources and levels of supporting evidence without altering the original candidate-selection procedure. Detailed gene-level evidence annotations are provided in Supplementary Table 1 . 2.3 Functional enrichment analysis of differentially expressed genes The Database for Annotation, Visualization and Integrated Discovery (DAVID) ( https://davidbioinformatics.nih.gov/ ) was used to perform Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis on the differentially expressed genes in ONFH. GO enrichment analysis mainly includes molecular function (MF), cellular component (CC), and biological process (BP), and the results were visualized using the Sangerbox platform ( http://sangerbox.com ). 2.4 ImmuCellAI analysis to determine immune cell infiltration SONFH and normal samples were compared for the abundance of 24 immune cell types using the ImmuCellAI algorithm ( https://guolab.wchscu.cn/ImmuCellAI/#!/ ). These immune cells included eighteen T cell subsets and six other essential immune cells, including B cells, macrophages, monocytes, neutrophils, dendritic cells (DCs), and natural killer cells (NK cells). First, we uploaded the previously acquired pyroptosis gene expression file from GC-induced femoral head necrosis. Next, we selected the immune cell abundance of each group for analysis and estimated the abundance of each immune cell type in both groups using this method. 2.5 Protein network construction, module analysis and candidate core gene analysis The STRING database ( https://string-db.org/ ) was used to create the protein-protein interaction (PPI) network of pyroptosis-related differentially expressed genes (DEGs) in GC-induced ONFH. Isolated nodes were eliminated; a confidence score threshold of 0.4 was set, and the network was optimized to retain interactions of pyroptosis-related DEGs. The PPI network was then visualized using Cytoscape software ( https://cytoscape.org/ ), and the pyroptosis-related DEGs were clustered using the Molecular Complex Detection (MCODE) plug-in. The CytoHubba plug-in within Cytoscape was utilized to pinpoint core genes in the PPI regulatory network. Five algorithms were employed to identify key nodes: degree, maximum clique centrality (MCC), maximum neighborhood component (MNC), density of maximum neighborhood component (DMNC), and edge percolated component (EPC). The top 20 node genes were identified from each algorithm, and the intersection was analyzed to determine the core genes. 2.6 Core gene screening and model building To further identify candidate biomarkers, two machine learning algorithms were applied. To prevent overfitting, the least absolute shrinkage and selection operator (Lasso) regression analysis was used to filter features. The Support Vector Machine-Recursive Feature Elimination (SVM-RFE) algorithm was selected for small sample data sets because it removes redundant features and retains only those related to the results. The pyroptosis-related differentially expressed genes (DEGs) identified from the intersection of these algorithms and CytoHubba were considered as candidate biomarkers. To evaluate the predictive value of each candidate biomarker, ROC curves were generated, and the area under the curve (AUC) with 95% confidence interval (CI) was calculated. The AUC ranges from 0.5 to 1.0, and the closer the AUC is to 1, the stronger the discriminative ability. 2.7 Human samples Femoral head tissues were collected from patients with glucocorticoid-induced ONFH and patients with femoral neck fracture undergoing hip arthroplasty. The study was approved by the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology (Approval number: UHCT-IEC-SOP-016-03-01), and written informed consent was obtained from all participants. Tissue samples were collected during surgery and immediately processed for RNA extraction and subsequent qRT-PCR analysis. 2.8 Mice preparation and treatment All animal experiments were carried out with the approval of the Animal Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology (Approval number: S4398). Mice were randomly assigned to the experimental treatment groups before treatment. In conditional knockout experiments, treatment allocation was randomized within each genotype. Investigators administering the treatments were not blinded to group allocation. To establish GC-induced ONFH, 20-week-old male C57BL/6J mice were injected intramuscularly with 20 mg/kg methylprednisolone (MPS) into the thigh, alternating sides on the first 3 days of a week for 3 weeks. Mice administered with saline served as controls. To evaluate the role of TREM1 in the femoral heads during GC-induced ONFH, mice were treated intraperitoneally with TREM1 antagonists LR12 (50 mg/kg) 30 minutes prior to each MPS or saline injection, every other day for 6 weeks. All mice were anesthetized with 1% pentobarbital sodium (50 mg/kg, intraperitoneal injection), and the femoral heads were harvested 6 weeks after the first injection. To examine the effects of endothelial-derived PGE2 on macrophages of the femoral heads, Cox2 flox/flox mice and Cox2 VE-Cadherin -/- mice were used to establish the GC-induced ONFH mouse model. First, mice carrying loxP-flanked Cox2 alleles ( Cox2 flox/flox ) and VE-Cadherin -Cre transgenic mice were crossed to obtain VE-Cadherin- Cre: Cox2 flox/− mice, which were then mated with Cox2 flox/flox mice to obtain VE-Cadherin- Cre: Cox2 flox/flox mice (Cox2 VE-Cadherin -/- ) . The VE-Cadherin -Cre mouse strain (stock no.: 006137) and the Cox2 flox/flox mouse strain (stock no.: 030785) were purchased from Jackson Laboratory. VE-Cadherin -Cre forward, AATCAACTGTGCTC-TCCAC; reverse, GGTCAGTAAATTGGACACCT; Cox2 loxP allele forward, TGCCCTTGTTG-TTGTTGTTG, reverse, TGGACGTAAACTCCTCTTCAGAC. 2.9 Western blotting The procedure for Western blotting was conducted as described earlier ( 16 ). In brief, lysis buffer (P0013, Beyotime) with a protease and phosphatase inhibitor cocktail (P1045, Beyotime) was used to completely lyse tissues and cells. Equal volumes of protein extracts (20 μg) were loaded onto PVDF membranes, blocked for one hour in 5% milk, and then incubated with primary antibodies for the overnight at 4 °C. After three rounds of washing, the membranes were incubated for one hour at room temperature with secondary antibodies. Following preparation using an enhanced chemiluminescence substrate kit (34577, Thermo Fisher Scientific), protein bands were then visualized using a Bio-Rad scanner. The primary antibodies used were as follows: TREM1 (1:1 000, 30496-1-AP, Proteintech), NF-κB p65 (1:1 000, 380172, Zenbio), Phospho-NF-κB p65 (1:1 000, 310012, Zenbio), NLRP3 (1:1 000, 30109-1-AP, Proteintech), ASC (1:1 000, 10500-1-AP, Proteintech), N-GSDMD/GSDMD (1:1000, ab209845, Abcam), cleaved-caspase-1/pro-caspase-1(1:1000, A28849, Abclonal), AKT (1:1 000, R23412, Zenbio), Phospho-AKT (1:1 000, 310021, Zenbio), p38 (1:1 000, 200782, Zenbio), Phospho-p38 (1:1 000, 310068, Zenbio), ERK1/2(1:1000, 4695, CST), Phospho-ERK1/2(1:2000, 4370, CST), JNK(1:1000, A4867, Abclonal), Phospho-JNK(1:1000, AP0631, Abclonal), β-actin (1:20 000, 66009-1-Ig, Proteintech). 2.10 qRT-PCR Total RNA was extracted from cultured cells utilizing TRIzol (15596026, Invitrogen) in accordance with the manufacturer’s guidelines. The Taq SYBR Green Power PCR Master Mix (A25777, Invitrogen) was utilized for quantitative PCR with a Step One Plus real-time PCR system (Applied Biosystems, Foster City, CA, USA), with β-actin serving as an internal control. A dissociation curve analysis was conducted for each experiment. Supplementary Tables 2 , 3 provides the primer sequences for qRT-PCR applicable to both mice and humans. 2.11 Isolation and culture of primary cells Primary osteoblasts (OBs), bone marrow-derived macrophages (M φ), bone marrow mesenchymal stromal cells (BMSCs), and femoral head endothelial cells (ECs) were obtained from mice under sterile conditions. For OB isolation, femurs and tibias were cleaned of surrounding soft tissues, flushed to remove bone marrow, cut into small fragments, and sequentially digested with collagenase type IA (300 U mL -1 ; Sigma-Aldrich). The osteoblast-enriched fractions were collected and cultured in α-MEM supplemented with serum and penicillin/streptomycin. For M φ preparation, bone marrow was flushed from the femurs and tibias and filtered through a 70-μm cell strainer. The collected cells were cultured in DMEM supplemented with 10% FBS, 1% penicillin/streptomycin, and M-CSF (20 ng mL -1 ) for 7 days to induce macrophage differentiation. BMSCs were obtained by flushing bone marrow from the femurs and tibias, followed by filtration through a 70-μm cell strainer. Cells were cultured in α-MEM containing 10% FBS and 1% penicillin/streptomycin. Non-adherent cells were removed by medium replacement, and the adherent cells were expanded for subsequent experiments. Femoral head ECs were isolated as previously described in our study ( 11 ). Briefly, femoral heads were minced and digested with collagenase A (SCR136, Sigma-Aldrich) for 30 min at 37 °C. ECs were subsequently enriched by magnetic-activated cell sorting using an EMCN antibody (sc-65495, Santa Cruz Biotechnology) and Dynabeads Sheep Anti-Rat IgG (11035, Thermo Fisher Scientific). The isolated ECs were cultured
## Related Clinical Research

- [Inferior turbinate IgG4-rich lymphoid hyperplasia mimicking IgG4-related disease](https://medichelpline.com/clinical-feed/frontiers-in-immunology-11-localized-lymphoid-hyperplasia-with-prominent-igg4-positive-plasma-cells-in-the.md)
- [Neutrophils' Bidirectional Regulation of Bone Metabolism: Mechanisms and Contextual Effects](https://medichelpline.com/clinical-feed/frontiers-in-immunology-8-the-bidirectional-role-of-neutrophils-in-the-regulation-of-bone-metabolism-a.md)
- [Understanding Vaccine Skepticism: Insights from Two Decades of Parental Conversations](https://medichelpline.com/clinical-feed/stat-news-1-she-s-spent-two-decades-talking-to-parents-who-don-t-vaccinate-their-children.md)
- [WHO director-general race: five candidates and questions about the U.S. role](https://medichelpline.com/clinical-feed/stat-news-1-at-least-five-candidates-vie-to-become-the-next-who-leader-as-questions-over-u.md)
- [Lifestyle strategies for ADT-induced osteosarcopenia and metabolic dysfunction in prostate cancer](https://medichelpline.com/clinical-feed/pubmed-43064850.md) (DOI: 10.1007/s00520-026-11504-1)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.